The reason why the increase in potassium level was found to be associated with mortality in our study was thought to be due to the fact that the GNRI calculation and laboratory values were calculated with venous blood samples taken at the first hospitalization of these patients, and that patients with hyperkalemia had reservations about using mineralocorticoid receptor antagonists. This evidence concerns the gene NR3C2 and Hyperkalemia.